Earnings Preview: Molson Coors Beverage

Molson Coors Beverage (NYSE:TAP) is set to give its latest quarterly earnings report on Tuesday, 2023-08-01. Here’s what…

Molson Coors Beverage (NYSE:TAP) is set to give its latest quarterly earnings report on Tuesday, 2023-08-01. Here’s what investors need to know before the announcement.

Analysts estimate that Molson Coors Beverage will report an earnings per share (EPS) of $1.59.

Molson Coors Beverage bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.28, which was followed by a 0.18% drop in the share price the next day.

Here’s a look at Molson Coors Beverage’s past performance and the resulting price change:

Quarter Q1 2023 Q4 2022 Q3 2022 Q2 2022
EPS Estimate 0.26 1.07 1.37 1.19
EPS Actual 0.54 1.30 1.32 1.19
Price Change % -0.18% -1.27% 1.17% 1.38%

eps graph

Stock Performance

Shares of Molson Coors Beverage were trading at $70.55 as of July 28. Over the last 52-week period, shares are up 30.22%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Molson Coors Beverage visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Celularity Announces Net Sales And Total Revenue Expectations; Expects Net Sales Of Its Biomaterial Products And Biobanking Businesses To Be In The Range Of $11.4M-$12.1M For Q4 2023 And $22.06M-$22.76M For FY23

Celularity expects net sales of its biomaterial products and biobanking businesses to be in the range of $11.4 million to $12.1 million for the fourth quarter 2023 and $22.06 million to $22.76 million for the full year

CELU